Author/Authors :
Erdoğan, Aşkın Başkent University - Faculty of Medicine - Department of Gastroenterology, Turkey , Kansu, Leyla Başkent University - Faculty of Medicine - Department of Otolarynngology-Head and Neck Surgery, Turkey , Akkaya, Hampar Başkent University - Faculty of Medicine - Deparment of Pathology, Turkey
Abstract :
A 55-year-old white woman receiving peginterferon alfa- 2a (180 mg) and ribavirin (1200 mg) combination therapy for hepatitis C virus (HCV; genotype 1b) infection complained of a burning sensation and discomfort in her tongue in the second month, and tongue hyperpigmentation in the fourth month of the therapy. Physical examination revealed hyperpigmentation on the lateral and dorsal parts of the tongue (Figure 1).
